nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—PRKCA—periosteum—osteoporosis	0.0703	0.742	CbGeAlD
Ingenol Mebutate—PRKCD—bone marrow—osteoporosis	0.0148	0.156	CbGeAlD
Ingenol Mebutate—Application site erythema—Estradiol—osteoporosis	0.0133	0.0566	CcSEcCtD
Ingenol Mebutate—Application site irritation—Estradiol—osteoporosis	0.0113	0.048	CcSEcCtD
Ingenol Mebutate—PRKCA—uterus—osteoporosis	0.00961	0.101	CbGeAlD
Ingenol Mebutate—Eyelid oedema—Estradiol—osteoporosis	0.00621	0.0264	CcSEcCtD
Ingenol Mebutate—Ulcer—Alendronate—osteoporosis	0.00617	0.0263	CcSEcCtD
Ingenol Mebutate—Ulcer—Ibandronate—osteoporosis	0.006	0.0256	CcSEcCtD
Ingenol Mebutate—Ulcer—Risedronate—osteoporosis	0.00495	0.0211	CcSEcCtD
Ingenol Mebutate—Swelling—Ibandronate—osteoporosis	0.00467	0.0199	CcSEcCtD
Ingenol Mebutate—Ulcer—Conjugated Estrogens—osteoporosis	0.00414	0.0176	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Ibandronate—osteoporosis	0.00369	0.0157	CcSEcCtD
Ingenol Mebutate—Swelling—Pamidronate—osteoporosis	0.00366	0.0156	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Calcitriol—osteoporosis	0.00361	0.0154	CcSEcCtD
Ingenol Mebutate—Swelling—Zoledronate—osteoporosis	0.00334	0.0142	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Estropipate—osteoporosis	0.00331	0.0141	CcSEcCtD
Ingenol Mebutate—Infestation—Estropipate—osteoporosis	0.00331	0.0141	CcSEcCtD
Ingenol Mebutate—Ulcer—Estradiol—osteoporosis	0.00331	0.0141	CcSEcCtD
Ingenol Mebutate—Eye pain—Zoledronate—osteoporosis	0.00327	0.0139	CcSEcCtD
Ingenol Mebutate—Swelling—Conjugated Estrogens—osteoporosis	0.00322	0.0137	CcSEcCtD
Ingenol Mebutate—Infestation—Ibandronate—osteoporosis	0.00318	0.0135	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Ibandronate—osteoporosis	0.00318	0.0135	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Raloxifene—osteoporosis	0.00312	0.0133	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Risedronate—osteoporosis	0.00304	0.0129	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Calcitriol—osteoporosis	0.00302	0.0129	CcSEcCtD
Ingenol Mebutate—Erythema—Etidronic acid—osteoporosis	0.00299	0.0127	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Pamidronate—osteoporosis	0.00289	0.0123	CcSEcCtD
Ingenol Mebutate—Eye disorder—Estropipate—osteoporosis	0.00278	0.0118	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Ethinyl Estradiol—osteoporosis	0.00269	0.0114	CcSEcCtD
Ingenol Mebutate—Infestation—Ethinyl Estradiol—osteoporosis	0.00269	0.0114	CcSEcCtD
Ingenol Mebutate—Eye disorder—Ibandronate—osteoporosis	0.00267	0.0113	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Zoledronate—osteoporosis	0.00264	0.0112	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Risedronate—osteoporosis	0.00262	0.0111	CcSEcCtD
Ingenol Mebutate—Infestation—Risedronate—osteoporosis	0.00262	0.0111	CcSEcCtD
Ingenol Mebutate—Erythema—Estropipate—osteoporosis	0.00259	0.011	CcSEcCtD
Ingenol Mebutate—Swelling—Estradiol—osteoporosis	0.00258	0.011	CcSEcCtD
Ingenol Mebutate—Erythema—Alendronate—osteoporosis	0.00255	0.0109	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Risedronate—osteoporosis	0.00254	0.0108	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Pamidronate—osteoporosis	0.00249	0.0106	CcSEcCtD
Ingenol Mebutate—Infestation—Pamidronate—osteoporosis	0.00249	0.0106	CcSEcCtD
Ingenol Mebutate—Erythema—Ibandronate—osteoporosis	0.00248	0.0106	CcSEcCtD
Ingenol Mebutate—Erythema—Calcitriol—osteoporosis	0.00243	0.0103	CcSEcCtD
Ingenol Mebutate—Infection—Etidronic acid—osteoporosis	0.00243	0.0103	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Pamidronate—osteoporosis	0.00242	0.0103	CcSEcCtD
Ingenol Mebutate—Infestation—Zoledronate—osteoporosis	0.00227	0.00968	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Zoledronate—osteoporosis	0.00227	0.00968	CcSEcCtD
Ingenol Mebutate—Eye disorder—Ethinyl Estradiol—osteoporosis	0.00225	0.00959	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Zoledronate—osteoporosis	0.00221	0.00941	CcSEcCtD
Ingenol Mebutate—Eye disorder—Risedronate—osteoporosis	0.0022	0.00935	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Conjugated Estrogens—osteoporosis	0.00219	0.00932	CcSEcCtD
Ingenol Mebutate—Infestation—Conjugated Estrogens—osteoporosis	0.00219	0.00932	CcSEcCtD
Ingenol Mebutate—Infection—Estropipate—osteoporosis	0.0021	0.00894	CcSEcCtD
Ingenol Mebutate—Eye disorder—Pamidronate—osteoporosis	0.00209	0.00889	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Estropipate—osteoporosis	0.00207	0.00882	CcSEcCtD
Ingenol Mebutate—Infection—Alendronate—osteoporosis	0.00207	0.0088	CcSEcCtD
Ingenol Mebutate—Infection—Raloxifene—osteoporosis	0.00203	0.00866	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Estradiol—osteoporosis	0.00203	0.00865	CcSEcCtD
Ingenol Mebutate—Infection—Ibandronate—osteoporosis	0.00201	0.00857	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Raloxifene—osteoporosis	0.00201	0.00854	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Ibandronate—osteoporosis	0.00199	0.00846	CcSEcCtD
Ingenol Mebutate—Erythema—Pamidronate—osteoporosis	0.00195	0.00828	CcSEcCtD
Ingenol Mebutate—Eye disorder—Zoledronate—osteoporosis	0.00191	0.00812	CcSEcCtD
Ingenol Mebutate—Eye disorder—Conjugated Estrogens—osteoporosis	0.00184	0.00782	CcSEcCtD
Ingenol Mebutate—Erythema—Zoledronate—osteoporosis	0.00178	0.00756	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Estradiol—osteoporosis	0.00175	0.00746	CcSEcCtD
Ingenol Mebutate—Infestation—Estradiol—osteoporosis	0.00175	0.00746	CcSEcCtD
Ingenol Mebutate—Erythema—Conjugated Estrogens—osteoporosis	0.00171	0.00728	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Estradiol—osteoporosis	0.0017	0.00725	CcSEcCtD
Ingenol Mebutate—Infection—Ethinyl Estradiol—osteoporosis	0.0017	0.00724	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00168	0.00715	CcSEcCtD
Ingenol Mebutate—Infection—Risedronate—osteoporosis	0.00166	0.00706	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Risedronate—osteoporosis	0.00164	0.00697	CcSEcCtD
Ingenol Mebutate—Infection—Pamidronate—osteoporosis	0.00158	0.00671	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Pamidronate—osteoporosis	0.00156	0.00663	CcSEcCtD
Ingenol Mebutate—Headache—Etidronic acid—osteoporosis	0.00153	0.00651	CcSEcCtD
Ingenol Mebutate—Eye disorder—Estradiol—osteoporosis	0.00147	0.00626	CcSEcCtD
Ingenol Mebutate—Infection—Zoledronate—osteoporosis	0.00144	0.00613	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Zoledronate—osteoporosis	0.00142	0.00605	CcSEcCtD
Ingenol Mebutate—Infection—Conjugated Estrogens—osteoporosis	0.00139	0.0059	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00137	0.00583	CcSEcCtD
Ingenol Mebutate—Erythema—Estradiol—osteoporosis	0.00137	0.00583	CcSEcCtD
Ingenol Mebutate—Headache—Estropipate—osteoporosis	0.00132	0.00563	CcSEcCtD
Ingenol Mebutate—Headache—Alendronate—osteoporosis	0.0013	0.00555	CcSEcCtD
Ingenol Mebutate—Headache—Raloxifene—osteoporosis	0.00128	0.00546	CcSEcCtD
Ingenol Mebutate—Headache—Ibandronate—osteoporosis	0.00127	0.0054	CcSEcCtD
Ingenol Mebutate—Headache—Calcitriol—osteoporosis	0.00124	0.00529	CcSEcCtD
Ingenol Mebutate—Infection—Estradiol—osteoporosis	0.00111	0.00473	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Estradiol—osteoporosis	0.0011	0.00466	CcSEcCtD
Ingenol Mebutate—Headache—Ethinyl Estradiol—osteoporosis	0.00107	0.00457	CcSEcCtD
Ingenol Mebutate—Headache—Risedronate—osteoporosis	0.00105	0.00445	CcSEcCtD
Ingenol Mebutate—Headache—Pamidronate—osteoporosis	0.000994	0.00423	CcSEcCtD
Ingenol Mebutate—Headache—Zoledronate—osteoporosis	0.000908	0.00387	CcSEcCtD
Ingenol Mebutate—Headache—Conjugated Estrogens—osteoporosis	0.000875	0.00372	CcSEcCtD
Ingenol Mebutate—Headache—Estradiol—osteoporosis	0.0007	0.00298	CcSEcCtD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—IL6R—osteoporosis	0.00034	0.000507	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—FGA—osteoporosis	0.000334	0.000498	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Myometrial Relaxation and Contraction Pathways—IL6—osteoporosis	0.000331	0.000493	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	0.000331	0.000493	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PNP—osteoporosis	0.000329	0.000491	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ATIC—osteoporosis	0.000329	0.000491	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—PSMA5—osteoporosis	0.000328	0.00049	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—PSMA2—osteoporosis	0.000328	0.00049	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.000328	0.00049	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Myometrial Relaxation and Contraction Pathways—IL1B—osteoporosis	0.000324	0.000484	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—CALCA—osteoporosis	0.000324	0.000483	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signal transduction—IL6—osteoporosis	0.000321	0.000479	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR—IL6—osteoporosis	0.000319	0.000476	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—IRS2—osteoporosis	0.000319	0.000475	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by ERBB2—IL6—osteoporosis	0.000318	0.000474	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—PSMA2—osteoporosis	0.000318	0.000474	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—PSMA5—osteoporosis	0.000318	0.000474	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—LRP5—osteoporosis	0.000318	0.000474	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SOST—osteoporosis	0.000317	0.000473	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—IGF1—osteoporosis	0.000317	0.000472	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—IRS2—osteoporosis	0.000316	0.000472	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 signaling—IL6—osteoporosis	0.000316	0.000472	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—PSMA2—osteoporosis	0.000316	0.000471	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—PSMA5—osteoporosis	0.000316	0.000471	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—RPL24—osteoporosis	0.000314	0.000469	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—MYC—osteoporosis	0.000314	0.000469	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—TGFB1—osteoporosis	0.000314	0.000468	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TLN1—osteoporosis	0.000313	0.000467	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—LRP6—osteoporosis	0.000304	0.000453	CbGpPWpGaD
Ingenol Mebutate—PRKCA—PDGFR-beta signaling pathway—MYC—osteoporosis	0.0003	0.000448	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IRAK3—osteoporosis	0.0003	0.000447	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—ENO1—osteoporosis	0.000298	0.000444	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 interactions—IL6—osteoporosis	0.000297	0.000444	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR in disease—IL6—osteoporosis	0.000297	0.000444	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR—IL6—osteoporosis	0.000295	0.00044	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PSMA2—osteoporosis	0.000293	0.000438	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PSMA5—osteoporosis	0.000293	0.000438	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—TNF—osteoporosis	0.000293	0.000437	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR in Cancer—IL6—osteoporosis	0.000292	0.000436	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—RPL24—osteoporosis	0.000292	0.000436	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—LTF—osteoporosis	0.000292	0.000436	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by PDGF—IL6—osteoporosis	0.000291	0.000434	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CALCR—osteoporosis	0.000287	0.000428	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PTH1R—osteoporosis	0.000287	0.000428	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—IGF1—osteoporosis	0.000284	0.000424	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—ESR2—osteoporosis	0.000282	0.000421	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—PTH—osteoporosis	0.000281	0.000419	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—OXCT1—osteoporosis	0.00028	0.000417	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CA2—osteoporosis	0.00028	0.000417	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—IRS1—osteoporosis	0.000278	0.000415	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—IRS1—osteoporosis	0.000276	0.000412	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—ACTG1—osteoporosis	0.000274	0.000409	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—CNR2—osteoporosis	0.000274	0.000408	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CALCA—osteoporosis	0.000273	0.000408	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—MGLL—osteoporosis	0.000273	0.000407	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—P4HB—osteoporosis	0.00027	0.000402	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—KL—osteoporosis	0.000269	0.000401	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—KL—osteoporosis	0.000265	0.000396	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—IL6—osteoporosis	0.000263	0.000393	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PTH—osteoporosis	0.000262	0.000391	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—IL6R—osteoporosis	0.000261	0.00039	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—IL6R—osteoporosis	0.000259	0.000387	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—RAP1A—osteoporosis	0.000258	0.000385	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CNR2—osteoporosis	0.000256	0.000382	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFA-VEGFR2 Pathway—IL6—osteoporosis	0.000256	0.000381	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—PTH—osteoporosis	0.000255	0.000381	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.000255	0.00038	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—ADCY5—osteoporosis	0.000254	0.000379	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—ACP5—osteoporosis	0.000253	0.000378	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NFATC1—osteoporosis	0.000252	0.000375	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—DKK1—osteoporosis	0.00025	0.000372	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CNR2—osteoporosis	0.000249	0.000371	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—KL—osteoporosis	0.000248	0.00037	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—IL6—osteoporosis	0.000241	0.00036	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—WNT1—osteoporosis	0.00024	0.000359	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—IL6—osteoporosis	0.000236	0.000353	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—TPI1—osteoporosis	0.000235	0.000351	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—FGA—osteoporosis	0.000234	0.000349	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—WNT1—osteoporosis	0.000234	0.000349	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—PTHLH—osteoporosis	0.000233	0.000347	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—IDH2—osteoporosis	0.000232	0.000346	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—ADCY5—osteoporosis	0.000231	0.000344	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—RAP1A—osteoporosis	0.000229	0.000342	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MGLL—osteoporosis	0.000228	0.00034	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CTSK—osteoporosis	0.000227	0.000339	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—VDR—osteoporosis	0.000224	0.000334	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—NFATC1—osteoporosis	0.000224	0.000333	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—LRP5—osteoporosis	0.000222	0.000332	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—P4HB—osteoporosis	0.000221	0.00033	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CYP27A1—osteoporosis	0.000218	0.000325	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PTHLH—osteoporosis	0.000217	0.000324	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—BMP2—osteoporosis	0.000217	0.000324	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—GAPDH—osteoporosis	0.000217	0.000324	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.000214	0.000319	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.000213	0.000318	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—LRP6—osteoporosis	0.000213	0.000317	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—FGB—osteoporosis	0.000213	0.000317	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ACP5—osteoporosis	0.000212	0.000316	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—PTHLH—osteoporosis	0.000211	0.000315	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—AGER—osteoporosis	0.000211	0.000315	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—ADCY5—osteoporosis	0.000211	0.000314	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—AGER—osteoporosis	0.000208	0.000311	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—ADCY5—osteoporosis	0.000208	0.00031	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NFATC1—osteoporosis	0.000206	0.000308	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—IL6—osteoporosis	0.000206	0.000307	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PSMA5—osteoporosis	0.000205	0.000306	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PSMA2—osteoporosis	0.000205	0.000306	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—CALCA—osteoporosis	0.000205	0.000306	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—IL6—osteoporosis	0.000205	0.000306	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—DKK1—osteoporosis	0.000205	0.000305	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—IL6—osteoporosis	0.000203	0.000302	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	0.000199	0.000297	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—WNT1—osteoporosis	0.000197	0.000294	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—TPI1—osteoporosis	0.000197	0.000294	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—IL6—osteoporosis	0.000196	0.000293	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—ADCY5—osteoporosis	0.000194	0.00029	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—FGA—osteoporosis	0.000192	0.000286	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CALCA—osteoporosis	0.000191	0.000286	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Myometrial Relaxation and Contraction Pathways—IL6—osteoporosis	0.00019	0.000283	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	0.00019	0.000283	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—POMC—osteoporosis	0.000187	0.000279	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CALCA—osteoporosis	0.000186	0.000278	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—P4HB—osteoporosis	0.000185	0.000276	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—IL6—osteoporosis	0.000184	0.000275	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IRS2—osteoporosis	0.000184	0.000275	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—IL6—osteoporosis	0.000183	0.000274	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—IL6—osteoporosis	0.000183	0.000272	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PSMA2—osteoporosis	0.000183	0.000272	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PSMA5—osteoporosis	0.000183	0.000272	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GAPDH—osteoporosis	0.000182	0.000271	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—IRS2—osteoporosis	0.000182	0.000271	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—IL6—osteoporosis	0.000182	0.000271	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—PSMA5—osteoporosis	0.000181	0.000271	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—PSMA2—osteoporosis	0.000181	0.000271	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TLN1—osteoporosis	0.00018	0.000268	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—MTHFR—osteoporosis	0.000179	0.000267	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—RAP1A—osteoporosis	0.000177	0.000264	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—KL—osteoporosis	0.000174	0.000259	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—ESR1—osteoporosis	0.000171	0.000255	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—ENO1—osteoporosis	0.000171	0.000255	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—IL6—osteoporosis	0.000171	0.000255	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—IL6—osteoporosis	0.000171	0.000255	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—TGFB1—osteoporosis	0.00017	0.000254	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—IRS2—osteoporosis	0.00017	0.000254	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—POMC—osteoporosis	0.00017	0.000253	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—IL6—osteoporosis	0.000169	0.000253	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PSMA2—osteoporosis	0.000169	0.000251	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PSMA5—osteoporosis	0.000169	0.000251	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—IL6—osteoporosis	0.000168	0.00025	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—IL6—osteoporosis	0.000167	0.000249	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—IL6R—osteoporosis	0.000165	0.000247	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—TGFB1—osteoporosis	0.000165	0.000246	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—IGF1—osteoporosis	0.000163	0.000243	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—ESR2—osteoporosis	0.000162	0.000242	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IRS1—osteoporosis	0.000161	0.00024	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—IRS1—osteoporosis	0.000159	0.000237	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CALCA—osteoporosis	0.000157	0.000234	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—P4HB—osteoporosis	0.000155	0.000231	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—KL—osteoporosis	0.000154	0.00023	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—IL6—osteoporosis	0.000151	0.000226	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IL6R—osteoporosis	0.000151	0.000225	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PTH—osteoporosis	0.000151	0.000225	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—IL6R—osteoporosis	0.000149	0.000222	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—IRS1—osteoporosis	0.000149	0.000222	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—RAP1A—osteoporosis	0.000148	0.000221	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CNR2—osteoporosis	0.000147	0.000219	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.000146	0.000218	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—ADCY5—osteoporosis	0.000146	0.000217	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NFATC1—osteoporosis	0.000145	0.000216	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—DKK1—osteoporosis	0.000143	0.000214	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ENO1—osteoporosis	0.000143	0.000214	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—MYC—osteoporosis	0.000143	0.000213	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—KL—osteoporosis	0.000143	0.000213	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PSMA5—osteoporosis	0.000141	0.00021	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PSMA2—osteoporosis	0.000141	0.00021	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—IL6R—osteoporosis	0.00014	0.000208	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—WNT1—osteoporosis	0.000138	0.000206	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—ADCY5—osteoporosis	0.000136	0.000203	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—FGA—osteoporosis	0.000134	0.0002	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—ADCY5—osteoporosis	0.000132	0.000198	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SPP1—osteoporosis	0.000132	0.000197	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—VDR—osteoporosis	0.000129	0.000192	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PTHLH—osteoporosis	0.000125	0.000186	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—BMP2—osteoporosis	0.000125	0.000186	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—FGB—osteoporosis	0.000122	0.000182	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—AGER—osteoporosis	0.000121	0.000181	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—ADCY5—osteoporosis	0.000121	0.00018	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IRS2—osteoporosis	0.000119	0.000178	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PSMA5—osteoporosis	0.000118	0.000176	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PSMA2—osteoporosis	0.000118	0.000176	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—LEP—osteoporosis	0.000117	0.000174	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—IL6—osteoporosis	0.000116	0.000174	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—IL6—osteoporosis	0.000116	0.000172	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IL1B—osteoporosis	0.000115	0.000172	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CYP19A1—osteoporosis	0.000114	0.000171	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—ADCY5—osteoporosis	0.000112	0.000167	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—ESR1—osteoporosis	0.000111	0.000166	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CALCA—osteoporosis	0.00011	0.000164	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—POMC—osteoporosis	0.000107	0.00016	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IRS2—osteoporosis	0.000106	0.000158	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IRS1—osteoporosis	0.000104	0.000155	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—MYC—osteoporosis	0.000104	0.000154	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MTHFR—osteoporosis	0.000103	0.000153	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—POMC—osteoporosis	0.0001	0.000149	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—KL—osteoporosis	9.99e-05	0.000149	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—ESR1—osteoporosis	9.83e-05	0.000147	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—TGFB1—osteoporosis	9.79e-05	0.000146	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—IRS2—osteoporosis	9.77e-05	0.000146	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IL6R—osteoporosis	9.77e-05	0.000146	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—POMC—osteoporosis	9.74e-05	0.000145	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IGF1—osteoporosis	9.64e-05	0.000144	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—IL6R—osteoporosis	9.5e-05	0.000142	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ADCY5—osteoporosis	9.35e-05	0.00014	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GPX1—osteoporosis	9.32e-05	0.000139	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—MYC—osteoporosis	9.26e-05	0.000138	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IRS1—osteoporosis	9.24e-05	0.000138	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—MYC—osteoporosis	8.91e-05	0.000133	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IL6R—osteoporosis	8.68e-05	0.000129	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—MTHFR—osteoporosis	8.6e-05	0.000128	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—IRS1—osteoporosis	8.53e-05	0.000127	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—MYC—osteoporosis	8.27e-05	0.000123	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—TGFB1—osteoporosis	8.25e-05	0.000123	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—IL6R—osteoporosis	8.01e-05	0.00012	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ADCY5—osteoporosis	7.82e-05	0.000117	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SPP1—osteoporosis	7.57e-05	0.000113	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—IL6—osteoporosis	7.37e-05	0.00011	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—POMC—osteoporosis	6.88e-05	0.000103	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IRS2—osteoporosis	6.84e-05	0.000102	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IL6—osteoporosis	6.73e-05	0.0001	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—LEP—osteoporosis	6.7e-05	9.99e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—IL6—osteoporosis	6.64e-05	9.9e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IL1B—osteoporosis	6.6e-05	9.85e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ESR1—osteoporosis	6.39e-05	9.54e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—IL6—osteoporosis	6.22e-05	9.27e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IRS1—osteoporosis	5.97e-05	8.91e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MYC—osteoporosis	5.79e-05	8.64e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TGFB1—osteoporosis	5.78e-05	8.62e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—POMC—osteoporosis	5.75e-05	8.58e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IL6R—osteoporosis	5.61e-05	8.37e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IGF1—osteoporosis	5.53e-05	8.25e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—MYC—osteoporosis	5.12e-05	7.63e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MYC—osteoporosis	4.75e-05	7.08e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—TGFB1—osteoporosis	4.74e-05	7.07e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IL6—osteoporosis	4.35e-05	6.49e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—IL6—osteoporosis	4.23e-05	6.31e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IL6—osteoporosis	3.87e-05	5.77e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—IL6—osteoporosis	3.57e-05	5.33e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MYC—osteoporosis	3.33e-05	4.96e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TGFB1—osteoporosis	3.32e-05	4.95e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IL6—osteoporosis	2.5e-05	3.73e-05	CbGpPWpGaD
